Neurotoxicity Society Sponsored SFN Satellite Meeting:

PROTECTION AGAINST NEURODEGENERATION: ARE THERE COMMON ENDOGENOUS MECHANISMS AND DOES PRECONDITIONING RESEARCH PROVIDE INSIGHTS?

Date: Friday, October 16th, 8:45 am to 5 pm.
Place:Beane Hall in Lewis Towers at Loyola University’s Water Tower Campus, 820 N. Michigan Ave., Chicago IL (www.mapquest.com/maps?city=Chicago&state=IL&address=820+N.+Michigan+Avenue; zoom to starred entry).
 
Annual SFN satellite symposium of the Neurotoxicity Society (NTS). Loyola University Water Tower Campus, Beane Hall, SW corner of North Michigan Ave. and Pearson St., Chicago. Friday, October 16th, 8:45 am to 5 pm.

This symposium sponsored by the NTS brings together neuroscience researchers with concepts and cutting edge results about endogenous neuroprotective mechanisms—often derived from preconditioning models—that could be of translational benefit in various neurodegenerative conditions. Confirmed presenters, listed alphabetically, and their tentative topics include :

SCHEDULE FOR SFN SATELLITE SYMPOSIUM:
“PROTECTION AGAINST NEURODEGENERATION: ARE THERE COMMON ENDOGENOUS MECHANISMS AND DOES PRECONDITIONING RESEARCH PROVIDE INSIGHTS?”
Friday, October 16, 2009 – Loyola University Chicago, Water Tower Campus, Beane Hall
Sponsored and supported by the Neurotoxicity Society (NTS)
with additional support from the Loyola University Neuroscience Institute (NI)
 
8:45 am  Introductory opening comments: Dr. Michael A. Collins, symposium organizer for NTS
            and Dr. Edward J. Neafsey, Loyola NI graduate director and executive board member
Section One: Mechanisms involving endogenous cytoprotectant neuroamines or enzymes.
Dr. Gidday and Dr. Collins, co-chairs
 9:00 DOUGLAS FEINSTEIN, Univ. of Illinois, Chicago
            “Importance of noradrenergic tone in Alzheimer’s and multiple sclerosis models”
            9:25 questions
 9:30 JOHN PILETZ, Loyola University Chicago
            “Neuroprotective role for endogenous agmatine in newborn hypoxia-ischemia”
            9:45 questions
10:00 JUAN SEGURA-AGUILAR, University of Chile, Santiago
            “Glutathione transferase M2-2 protects against dopamine oxidation product toxicity in astrocytes”
            10:25 questions
10:30 COFFEE/TEA/ROLLS
Section Two: Neuroprotective ischemic and/or hypoxic preconditioning mechanisms, part I.
Dr. Yenari and Dr. Cadet, co-chairs
10:45 DAVID BUSIJA, Wake Forest University
            “Mitochondrial targeting in neuroprotection”
            11:10 questions
11:15 JEFFREY GIDDAY, Washington University
            “Hypoxic preconditioning-induced expression of survival genes”
            11:40 questions
11:45 ANN MARINI, Uniformed Services University of the Health Sciences
            “Preconditioning by upregulating neuronal survival pathways”
            12:10 pm questions

12:15 pm LUNCH

Section Three: Neuroprotective ischemic and/or hypoxic pre (and post)conditioning mechanisms, part II.
Dr. Neafsey and Dr. Marini, co-chairs
1:30 MIGUEL PEREZ-PINZON, University of Miami
            “Role of PKC, sirtuins and STATS in cerebral ischemic tolerance”
            1:55 questions
2:00 JULIE SAUGSTAD, Legacy Research, Portland
            “Role for microRNA’s in preconditioning-induced tolerance”
            2:25 questions
2:30 HENG ZHAO, Stanford University
            “Protective effects and underlying mechanisms of ischemic postconditioning against stroke”      
            2:55 questions
3:00 COFFEE/TEA/FRUIT
Section Four: Neuroprotective mechanisms in other preconditioning approaches.
Dr. Feinstein and Dr. Saugstad, co-chairs
3:15 FERNANDO GÓMEZ-PINILLA, University of California, Los Angeles
            “Diet and exercise therapy for CNS trauma”
            3:40 questions
3:45 MIDORI YENARI, University of California, San Francisco
            “Therapeutic hypothermia and NFκB suppression”
            3:10 questions
3:15 JEAN LUD CADET, NIH/NIDA
            “Methamphetamine (MA) preconditioning reprograms transcriptional responses to MA-induced injury”
            3:40 questions
4:45 MICHAEL COLLINS, Loyola University Chicago
            “Possible NMDAR, PKC and FAK mechanisms in alcohol preconditioning neuroprotection”
            5:10 questions
5:15 WRAP UP: OPEN DISCUSSION/DEBATE and QUESTIONS involving all presenters

Download the program

Registration is through the NTS website online payment

Beverages and lunch for speakers and registrants will be provided on site.

CONTACT:
Michael A. Collins, PhD
E-Mail: mcollin@lumc.edu